Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy

PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy

US Patent 12233137 · Granted Feb 25, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compounds as kinase inhibitor and uses thereof2025
Targeted nanoparticle for the treatment of traumatic brain injury and other CNS 2025
Dopamine D3 receptor selective antagonists/partial agonists; method of making; a2024
Methods and related aspects for pathology prognosis2024
Imaging and radiotherapeutics agents targeting fibroblast-activation protein-α (2024
PSMA-based molecular-genetic reporter system2024
Dopamine D3 receptor selective antagonists/partial agonists and uses thereof2024
PSMA-binding agents and uses thereof2024
PSMA-binding agents and uses thereof2024
PSMA targeted fluorescent agents for image guided surgery2024
PSMA targeted fluorescent agents for image guided surgery2024
PSMA targeted fluorescent agents for image guided surgery2024